Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Guilford Gliadel Glioma Trial Shows Consistent Modest Benefit – Cmte.

Dec 10 2001

• By The Pink Sheet

Related Content

Guilford Seeks To Triple Gliadel Market With First-Line Indication

Apr 09 2001

Guilford Gliadel First-Line Use: Data Stratification To Be Considered By Cmte.

Sep 17 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window